ArticleCancer medicine2019

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study.

Rohit Bishnoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.